Prostate cancers are detected on the basis of elevated plasmatic levels of prostate-specific antigen (PSA > 4 ng/mL), a serine protease expressed solely in prostate tissue that acts in cancer pathophysiology by cleaving several growth regulatory proteins [44,46,47]. This evidence concerns the gene KLK3 and prostate cancer.